Evidence map›Paper›PMID 34681917›Full record

ArticleInternational journal of molecular sciences2021

The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells.

Ignazia Tusa, Sinforosa Gagliardi, Alessandro Tubita, Silvia Pandolfi, Alessio Menconi, Matteo Lulli, Persio Dello Sbarba, Barbara Stecca, Elisabetta Rovida

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. GLI1 Coamplification in Well-Differentiated/Dedifferentiated Liposarcomas: Clinicopathologic and Molecular Analysis of 92 Cases.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Targeting MAPK in Cancer 2.0.International journal of molecular sciences · 2022
    Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ignazia TusaDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, 50134 Florence, Italy.
Sinforosa GagliardiCore Research Laboratory-Institute for Cancer Research and Prevention (ISPRO), 50134 Florence, Italy.
Alessandro TubitaDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, 50134 Florence, Italy.
Silvia PandolfiCore Research Laboratory-Institute for Cancer Research and Prevention (ISPRO), 50134 Florence, Italy.
Alessio MenconiDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, 50134 Florence, Italy.
Matteo LulliDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, 50134 Florence, Italy.ORCID 0000-0002-8528-4094
Persio Dello SbarbaDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, 50134 Florence, Italy.
Barbara SteccaCore Research Laboratory-Institute for Cancer Research and Prevention (ISPRO), 50134 Florence, Italy.ORCID 0000-0003-1197-1622
Elisabetta RovidaDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, 50134 Florence, Italy.ORCID 0000-0002-5949-3239
University of Florence · ITPiedmont Reference Center for Epidemiology and Cancer Prevention · IT

Funding

Italian Association for Cancer Research IG-14184Italian Association for Cancer Research IG-15282Italian Association for Cancer Research IG-21349Italian Association for Cancer Research IG-23091Italian Association for Cancer Research/FIRC ID-23847
6 · The paper itself

Abstract

Malignant melanoma is the deadliest skin cancer, with a poor prognosis in advanced stages. We recently showed that the extracellular signal-regulated kinase 5 (ERK5), encoded by the

Indexed as

AnimalsCell LineCell ProliferationCell SurvivalChromatin ImmunoprecipitationCutaneous Malignant MelanomaGene Expression Regulation, NeoplasticHedgehog ProteinsHEK293 CellsHumansMAP Kinase Kinase 5MelanomaMiceMitogen-Activated Protein Kinase 7NIH 3T3 CellsPatched-1 ReceptorGLI1 protein, humanHedgehog ProteinsMAP2K5 protein, humanMAPK7 protein, humanMAP Kinase Kinase 5Mitogen-Activated Protein Kinase 7Patched-1 ReceptorPTCH1 protein, humanZinc Finger Protein GLI1ERK5/MAPK7GLIHedgehogmelanomatargeted therapy

Identifiers

PMID34681917
PMCPMC8538987
OpenAlexW3206914048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.